Lecture 3: Intro to Pharmacodynamics Flashcards

1
Q

What is the major difference between Pharmacokinetics and Pharmacodynamics?

A

PK = effects of the body on drugs (ADME)

PD = effects of the drugs on the body
- receptors, response curves, drug action mech.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do Emax and ED50 on a logarithmic dose-response curve tell us?

A

Emax (on y-axis) is the maximal effect that can be produced by the drug

ED50 (on x-axis) is the dose of drug that produces 50% of its maximal effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does a Graded vs Quantal Dose-Response curve answer?

A

Graded answers: “How much?”
- usually the mean value in a pop. or single subject

Quantal answers: “Does the response occur or not?” and “How many?”

  • usually all-or-none, yes/no, or binary responses
  • examines frequency of a response in large pop.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the difference between a Non-Cumulative vs Cumulative Quantal Dose Curve?

A
  • non-cumulative shows number/% of pts responding to drug dose ONLY at that dose
  • cumulative shows number/% of pts responding to drug dose and at all doses lower than that dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the Therapeutic Index and how is it calculated?

A

TI = TD50 / ED50 (higher TI = safer drug)

TD50 = median toxic dose
ED50 = median effective dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is Drug Potency and how is it related to median effective dose? (ED50)

A
  • the amount of drug required to produce a specific pharmacological effect
  • lower ED50 means the drug is MORE potent and helps determine the drug does that will be used clinically
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Drug Efficacy and how is it related to Emax?

A
  • describes the pharmacological effect that a drug can produce (represented as Emax)
  • greater Emax means the drug is MORE efficacious and is related to the total number of receptors available to bind a drug
  • determines magnitude of clinical effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the difference between a Covalent bond and Non-Covalent bond?

A

Covalent: irreversible; requires re-synthesis of receptor or enzymatic removal of the drug

Non-Covalent: reversible; most drugs bind to receptors this way

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the 3 major Non-Covalent bonds from strongest to weakest?

A

Ionic (electostatic interactions)
Hydrogen
Hydrophobic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between a high affinity and low affinity drug?

A
  • HIGH affinity drugs have strong receptor binding and require less drug to produce a response
  • LOW affinity drugs have poor receptor binding and require more drug to produce a reponse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the Equilibrium Dissociation Constant (Kd) and why is it important for drug interaction?

A
  • Kd represents the drug concentration at which 50% of the drug receptor binding sites are occupied
  • LOWER Kd = HIGHER affinity of drug for receptor
  • HIGHER Kd = LOWER affinity of drug for receptor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is drug selectivity measured? How is selectivity related to adverse effects?

A
  • via Kd ratio = Kd (off target) / Kd (on target)
  • higher Kd ratio means the a drug is more selective
  • more selective drugs have fewer adverse effects, while less selective drugs have more adverse effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Intrinsic Activity and how does it relate to drug Agonists and Antagonists?

A
  • the ability of a drug to change receptor function and produce a physiological response when bound

Agonists - have intrinsic activity
Antagonists - have NO intrinsic activity
bind to receptor but do NOT change its function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the difference between Full Agonists, Partial Agonists, and Inverse Agonists?

A

Full - fully activate receptors (maximal intrinsic activity)

Partial - partially activate receptors (sub-max effects)

Inverse - produce opposite effect to other agonists
- dec. receptor signaling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the difference between Pharmacological, Chemical, and Physiological Antagonism?

A

Pharm - antagonism at receptors

Chemical - chemical antagonist makes other drug unavailable

Phys - endogenous pathway blocks other pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the difference between Irreversible and Allosteric Non-Competitive antagonists?

A
  • Irreversible bind to agonist site on receptor with COVALENT bonds
  • Non-Competitive bind to site other than agonist and prevent agonist binding/receptor activation
17
Q

How does Agonist EC50 and Emax change in the presence of a competitive and non-competitive antagonist?

A

Competitive - EC50 inc., Emax does not change

Non-comp - Emax dec., EC50 does not change

18
Q

What does Gs, Gi, Gq, and G12/13 activate in their pathways when activated?

A

Gs –> adenylate cyclase ACTIVATION
Gi –> adenylate cyclase INHIBITION

Gq –> Phospholipase C ACTIVATION
G12/13 –> Rho GTPases = cytoskeletal rearrangements

19
Q

How does G protein receptor resensitization occur using GRK, Beta-arrestin, and P’ase?

A
  • GRK phosphorylates receptors, preventing interaction with G subunit and allows Beta-arrestin binding
  • Beta-arrestin binds to coated pits, allowing for receptor internalization
  • agonist dissociation dec. Beta-arrestin affinity, allowing P’ase to dephosphorylate receptors
  • receptor is returned to the plasma membrane

prolonged or repeated agonist exposure leads to lysosomal breakdown of receptor

20
Q

What is the second messenger in the G protein pathway and what creates it? What breaks it down?

A
  • cAMP
  • created by adenylate cyclase from ATP
  • Phosphodiesterase converts cAMP into 5’-AMP
21
Q

What 5 molecules activate the JAK-STAT pathway? (GELII)

A
  • growth hormone (somatotropin)
  • erythropoietin
  • leptin
  • interferons
  • interleukins 2-10, 15
22
Q

What 6 molecules activate the RTK pathway? (IIVENP)

A
  • IGF-1 (insulin-like growth factor 1)
  • insulin
  • VEGF (vascular endothelial growth factor)
  • EGF (epidermal growth factor)
  • NGF (nerve growth factor)
  • PDGF (platelet-derived growth factor)
23
Q

Ras GTPase activation via Receptor Tyrosine Kinase

A
  • adaptor protein binds to phosphorylated tyrosine in cytoplasmic receptor domain
  • Ras activating protein binds to adaptor protein to activate Ras GTPase
  • Ras GTPase activate Raf –> MEK –> ERK 1/2
24
Q

What are 5 common activators of nuclear receptors? (STDAL)

A
  • usually lipophilic molecules that are able to cross the cell membrane
  • steroid hormones, thyroid hormones, vitamins A and D, and lipid mediators (FFAs)
  • heat-shock proteins bind to receptor in absence of ligand to prevent unwanted folding
25
Q

What drug blocks L-type calcium channels?

A

Verapamil

26
Q

How does Verapamil effect the SA and AV node and what does it help treat?

A

SA: lowers heart rate
AV: lower conductivity

helps treat atrial and supraventricular arrhythmias

27
Q

How does Verapamil effect cardiomyocytes and what does it help treat?

A

decreases contractility and oxygen demand

helps treat Angina pectoris

28
Q

How does Verapamil effect vascular smooth muscle and what does it help treat?

A

relaxes smooth muscle

helps treat hypertension

29
Q

How does Verapamil effect non-vascular smooth muscle and what is a side-effect that it can cause?

A

can cause muscle relaxation in the gut

can lead to constipation